Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    FDA Adds Warning Label To Obesity Drugs For Eye Condition

    1 hour ago

    The US Food and Drug Administration will now require GLP-1 drugs including Novo's Wegovy and Ozempic and Lilly's Mounjaro, Zepbound and Foundayo to carry warnings that they may increase the risk of non-arteritic anterior ischemic optic neuropathy, or NAION.
    Click here to Read More
    Previous Article
    Energy Drinks May Raise Risk Of Heart Problems In Young Adults: Study
    Next Article
    Japan Masters 2026: Schedule, Live Streaming, Indian Shuttlers In Action And Prize Money

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment